# LG Chem clinical trials: 71 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 71 trials with LG Chem as lead sponsor, 5 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by LG Chem: 71 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/lg-chem

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 71
- Recruiting or not yet: 5
- Read on: November 19, 2026

## Trials

The 25 newest of 71, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 7, 2026 | NCT07752875 | A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation | LG Chem | Phase 1/2 | Not yet recruiting | Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer, Colorectal Cancer, Esophageal Cancer, Breast... | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07752875) |
| July 17, 2026 | NCT07710430 | A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty | LG Chem | Phase 4 | Recruiting | Central Precocious Puberty | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07710430) |
| February 10, 2026 | NCT07399470 | A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and... | LG Chem | Phase 1 | Completed | Healthy Volunteers, Fasting Conditions | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07399470) |
| February 9, 2026 | NCT07396844 | The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers | LG Chem | Phase 1 | Completed | Healthy, Fasting, Fed | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07396844) |
| January 12, 2026 | NCT07333742 | A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is... | LG Chem | Phase 1 | Completed | Fed Conditions, Healthy Volunteer | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07333742) |
| April 27, 2025 | NCT06947499 | A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent... | LG Chem | Phase 2/3 | Active not recruiting | Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Haemophilus Influenzae Type b | 1,186 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06947499) |
| April 10, 2025 | NCT06921395 | Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile... | LG Chem | Phase 4 | Active not recruiting | Female Infertility | 248 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06921395) |
| December 20, 2024 | NCT06743997 | A Study to Compare Eutropin Formulations in Healthy Volunteers for Bioavailability, Safety, and Tolerability | LG Chem | Phase 1 | Completed | Healthy Volunteers | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06743997) |
| October 1, 2024 | NCT06618196 | Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months... | LG Chem | Phase 2 | Unknown | Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Haemophilus Influenzae Type B Infection | 336 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06618196) |
| July 10, 2024 | NCT06495281 | Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus Patients | LG Chem | Observational | Completed | Type 2 Diabetes Mellitus | 2,044 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06495281) |
| March 27, 2024 | NCT06333977 | A Study of LC542019 in Healthy Subjects and Subjects With T2DM | LG Chem | Phase 1 | Completed | Healthy, Diabetes Mellitus, Type 2 | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06333977) |
| March 27, 2024 | NCT06332755 | Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of... | LG Chem | Phase 1 | Recruiting | Non-small Cell Lung Cancer(NSCLC), Head and Neck Squamous Cell Carcinoma(HNSCC), Renal Cell Carcinoma(RCC), Urothelial... | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06332755) |
| January 16, 2024 | NCT06206135 | Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil Capsule | LG Chem | Observational | Recruiting | Hyperphosphatemia | 172 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06206135) |
| January 3, 2024 | NCT06189404 | Effect of Tigulixostat on the Pharmacokinetics of Theophylline | LG Chem | Phase 1 | Completed | Gout, Hyperuricemia | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06189404) |
| September 18, 2023 | NCT06041841 | A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic Obesity | LG Chem | Phase 2 | Unknown | POMC Deficiency Obesity, PCSK1 Deficiency Obesity, LEPR Deficiency Obesity | 4 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06041841) |
| September 15, 2023 | NCT06040372 | A First in Human Study to Assess the Safety, Tolerability of LB54640 in in Healthy Overweight and Obese Subjects | LG Chem | Phase 1 | Completed | Obese, Overweight, Healthy | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06040372) |
| July 19, 2023 | NCT05952596 | A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults | LG Chem | Phase 1 | Unknown | Diphtheria, Tetanus, Pertussis, Poliomyelitis, Hepatitis B, Haemophilus Influenzae Type b Infection | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05952596) |
| October 19, 2022 | NCT05586971 | Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients | LG Chem | Phase 3 | Completed | Gout, Hyperuricemia, Gout Flare, Tophi | 2,202 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05586971) |
| October 19, 2022 | NCT05586958 | Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients | LG Chem | Phase 3 | Completed | Gout, Hyperuricemia, Gout Flare, Tophi | 354 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05586958) |
| July 14, 2022 | NCT05457946 | Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series | LG Chem | Phase 2/3 | Completed | Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Haemophilus Influenzae Type B Infection | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05457946) |
| June 24, 2022 | NCT05431933 | Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary... | LG Chem | Phase 3 | Completed | Poliomyelitis, Vaccine Reaction | 2,001 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05431933) |
| April 6, 2022 | NCT05314504 | Clinical Investigation of YVOIRE Y-Solution 360 for Lip Augmentation in China | LG Chem | Not applicable | Completed | Lip Augmentation | 174 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05314504) |
| March 15, 2022 | NCT05281029 | Observational Study Gemigliptin in Patients Aged ≥ 65 Years With Type 2 Diabetes Mellitus | LG Chem | Observational | Unknown | Type 2 Diabetes Mellitus | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05281029) |
| February 14, 2022 | NCT05237752 | A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of LG00034053 in Patients With Knee OA | LG Chem | Phase 1/2 | Completed | Osteoarthritis, Knee | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05237752) |
| November 22, 2021 | NCT05130125 | Retrospective Cohort Observational Study to Evaluate the Effectiveness and Safety of Fresh or Frozen Embryo Transfer | LG Chem | Observational | Completed | Infertility, Female | 1,166 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05130125) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 1 | 32 |
| Phase 1/2 | 2 |
| Phase 2 | 6 |
| Phase 2/3 | 3 |
| Phase 3 | 5 |
| Phase 4 | 5 |
| Not applicable | 8 |
| Observational | 9 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 44 |
| Unknown | 17 |
| Recruiting | 4 |
| Terminated | 2 |
| Active not recruiting | 2 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Diabetes Mellitus, Type 2 | 10 |
| Gout | 10 |
| Hyperuricemia | 10 |
| Poliomyelitis | 8 |
| Diphtheria | 7 |
| Tetanus | 7 |
| Whooping Cough | 7 |
| Hepatitis B | 7 |
| Haemophilus Infections | 7 |
| Colitis, Ulcerative | 2 |
| Pneumococcal Infections | 2 |
| Infertility, Female | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Osteoarthritis | 1 |
| Puberty, Precocious | 1 |
| Obesity | 1 |
| Overweight | 1 |
| Dwarfism, Pituitary | 1 |
| Turner Syndrome | 1 |
| Kidney Failure, Chronic | 1 |
| Squamous Cell Carcinoma of Head and Neck | 1 |
| Carcinoma, Renal Cell | 1 |
| Carcinoma, Transitional Cell | 1 |
| Melanoma | 1 |
| Hypertension | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Leather products manufacturers in the United States](https://specstream.ai/data/businesses/leather-products-manufacturers/united-states)
- [International fusion restaurants in the United States](https://specstream.ai/data/businesses/international-fusion-restaurants/united-states)
- [Honduran restaurants in the United States](https://specstream.ai/data/businesses/honduran-restaurants/united-states)
- [Genetics practices in the United States](https://specstream.ai/data/businesses/genetics-practices/united-states)
- [Fertility clinics in the United States](https://specstream.ai/data/businesses/fertility-clinics/united-states)
- [Emergency departments in the United States](https://specstream.ai/data/businesses/emergency-departments/united-states)
